Synergistic Effect of a Mesothelin-Targeted <sup>227</sup>Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
Katrine Wickstroem(Bayer (Norway)), Alan Cuthbertson(Bayer (Norway))
Cited by 51
Related Papers
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344
|International Journal of Radiation Oncology*Biology*Physics|2019|27